Goldman Sachs Group Inc Zymergen Inc. Transaction History

Goldman Sachs Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 14, 2024	SELL	$1.2 - $3.37 $34,107 - $95,785	-28,423 Reduced 13.72%	178,782 $497,000
Q3 2022 Nov 10, 2022	SELL	$1.2 - $3.37 $34,107 - $95,785	-28,423 Reduced 13.72%	178,782 $0
Q2 2022 May 14, 2024	BUY	$1.12 - $3.03 $232,069 - $627,831	207,205 New	207,205 $255,000
Q2 2022 Aug 15, 2022	SELL	$1.12 - $3.03 $34,992 - $94,666	-31,243 Reduced 13.1%	207,205 $255,000
Q1 2022 May 16, 2022	SELL	$2.88 - $7.02 $6,062 - $14,777	-2,105 Reduced 0.88%	238,448 $688,000
Q4 2021 Feb 17, 2022	SELL	$6.53 - $14.19 $6.56 Million - $14.3 Million	-1,005,082 Reduced 80.69%	240,553 $1.61 Million
Q4 2021 Feb 14, 2022	BUY	$6.53 - $14.19 $6.98 Million - $15.2 Million	1,068,995 Added 605.18%	1,245,635 $8.33 Million
Q3 2021 Nov 10, 2021	BUY	$8.25 - $41.0 $1.46 Million - $7.24 Million	176,640 New	176,640 $2.33 Million

5.49M

Ticker ZY
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 104,355,000
Market Cap $254M
Description
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to co...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.